$ 59.99Add to cart
Bonothyrk - the complex of peptide fractions obtained from parathyroid young animals. The isolated peptides have a selective effect on parathyroid cells, they normalize metabolism, improve their functional activity. In a clinical study set Bonothyrk effectiveness in restoring functional activity of the parathyroid glands in disorders of various origins, including in hyperparathyroidism, including osteoporosis, demineralization of bone, kidney stones, muscle weakness, as well as hypoparathyroidism, including hypocalcemia, muscle cramps, stiff muscles.
The peptide bioregulator Bonothyrk normalizes the production of parathyroid hormone in the parathyroid glands, thus has a regulating effect on the level of calcium in the body, and calcium-phosphorus metabolism. Parathyroid gland nevrnoy affect the operation of the system, bone tissue and internal organs of some work.
Have the effect of peptide bioregulators Bonothyrk
The functions of the parathyroid glands
Parathyroid glands provide normal levels of calcium in the body, regulating the structure of bone, correct muscle contractility and secrete parathyroid hormone.
The operating principle of the peptide bioregulator Bonothyrk
The peptide bioregulator Bonothyrk acts at the level of parathyroid cells. All known protein composed of peptides from amino acids and peptides. Each type of protein, each body has their own unique set of peptide. Therefore, peptides, designed for specific bodies, getting into the body, combined with a DNA chain in strict adherence to them and rebuild a cyclical process of synthesis of new proteins. Thus the state of normal tissue of the parathyroid glands, their metabolism and function.
Peptide bioregulators exert their effects specifically. They "seek out" hearth problems and act locally. This principle of operation is based and Bonothyrk drug.
The results of applying the peptide bioregulator Bonothyrk
As a result of long-term clinical trials of peptide bioregulators Bonothyrk shown high efficacy in the treatment and prevention of osteoporosis, muscle weakness and disorders of muscle contractile capacity (due to disruption of the parathyroid glands), as well as other diseases.
The results of the application:
The peptide bioregulator Bonothyrk recommended for use in osteoporosis, and diseases caused by disruption of the parathyroid glands.
Adults take 1-2 capsules 1-2 times a day with meals. The duration of the 1-3 months. It is advisable to repeat the course in 1-3 months.
Important notice - the outer box design may vary before prior notice!